Cargando…

A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo

Aggressive forms of breast cancer, such as Her2(+) and triple negative breast cancer (TNBC), are enriched in breast cancer stem cells (BCSC) and have limited therapeutic options. BCSC represent a key cellular reservoir for relapse, metastatic progression and therapeutic resistance. Their ability to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolli, Elisabetta, O'Rourke, John P., Conti, Laura, Lanzardo, Stefania, Rolih, Valeria, Christen, Jayne M., Barutello, Giuseppina, Forni, Marco, Pericle, Federica, Cavallo, Federica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790338/ https://www.ncbi.nlm.nih.gov/pubmed/29399412 http://dx.doi.org/10.1080/2162402X.2017.1408746

Ejemplares similares

Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer
por: Rolih, Valeria, et al.
Publicado: (2020)

Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models
por: Barutello, Giuseppina, et al.
Publicado: (2022)

Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs’ Revolution for Immunotherapy
por: Barutello, Giuseppina, et al.
Publicado: (2018)

CSPG4: a prototype oncoantigen for translational immunotherapy studies
por: Rolih, Valeria, et al.
Publicado: (2017)

Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies
por: Magri, Jolanda, et al.
Publicado: (2021)

Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice
por: Conti, Laura, et al.
Publicado: (2014)

Role and Involvement of TENM4 and miR-708 in Breast Cancer Development and Therapy
por: Peppino, Giulia, et al.
Publicado: (2022)

Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models
por: Ruiu, Roberto, et al.
Publicado: (2023)

Antitumor immunization of mothers delays tumor development in cancer-prone offspring
por: Barutello, Giuseppina, et al.
Publicado: (2015)

Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis
por: Macagno, Marco, et al.
Publicado: (2022)

Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2(+) mammary cancer
por: Jacca, Sarah, et al.
Publicado: (2015)

Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice
por: Bandini, Silvio, et al.
Publicado: (2013)

A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors
por: Arigoni, Maddalena, et al.
Publicado: (2012)

L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents
por: Conti, Laura, et al.
Publicado: (2016)

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
por: Caldeira, Jerri C., et al.
Publicado: (2020)

A Mathematical-Biological Joint Effort to Investigate the Tumor-Initiating Ability of Cancer Stem Cells
por: Fornari, Chiara, et al.
Publicado: (2014)

Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota
por: Di Lorenzo, Antonino, et al.
Publicado: (2020)

Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer
por: Ruiu, Roberto, et al.
Publicado: (2021)

Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial
por: Riccardo, Federica, et al.
Publicado: (2022)

Maternal Immunization: New Perspectives on Its Application Against Non-Infectious Related Diseases in Newborns
por: Riccardo, Federica, et al.
Publicado: (2017)

Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy?
por: Ruiu, Roberto, et al.
Publicado: (2022)

Multi-level model for the investigation of oncoantigen-driven vaccination effect
por: Cordero, Francesca, et al.
Publicado: (2013)

The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
por: Salemme, Vincenzo, et al.
Publicado: (2021)

Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas
por: Riccardo, Federica, et al.
Publicado: (2020)

Teneurins: Role in Cancer and Potential Role as Diagnostic Biomarkers and Targets for Therapy
por: Peppino, Giulia, et al.
Publicado: (2021)

A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model
por: Msaki, Aichi, et al.
Publicado: (2016)

Angiomotin like-1 is a novel component of the N-cadherin complex affecting endothelial/pericyte interaction in normal and tumor angiogenesis
por: Zheng, Yujuan, et al.
Publicado: (2016)

Inhibition of JAK3 with a novel, selective, and orally active small molecule induces therapeutic response in T-cell malignancies
por: Ross, Jeremy A., et al.
Publicado: (2013)

Protection of mice against the highly pathogenic VV(IHD-J) by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity
por: Bissa, Massimiliano, et al.
Publicado: (2016)

Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy
por: Di Lorenzo, Antonino, et al.
Publicado: (2022)

xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain
por: Ungard, Robert G, et al.
Publicado: (2019)

Inflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice
por: Calogero, Raffaele Adolfo, et al.
Publicado: (2007)

2011: the immune hallmarks of cancer
por: Cavallo, Federica, et al.
Publicado: (2011)

The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
por: Jyotsana, Nidhi, et al.
Publicado: (2022)

Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
por: Koppula, Pranavi, et al.
Publicado: (2020)

Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT‐targeted therapy
por: Otsuki, Yuji, et al.
Publicado: (2019)

xCT-Driven Expression of GPX4 Determines Sensitivity of Breast Cancer Cells to Ferroptosis Inducers
por: Lee, Namgyu, et al.
Publicado: (2021)

Butyrate reverses ferroptosis resistance in colorectal cancer by inducing c-Fos-dependent xCT suppression
por: He, Ying, et al.
Publicado: (2023)

Neurology of cancer immunotherapy
por: De Grado, Amedeo, et al.
Publicado: (2022)

xCT increases tuberculosis susceptibility by regulating antimicrobial function and inflammation
por: Cai, Yi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p9uun7sm88h28fm23eec7av7is